Rybelsus 7 mg Tablet contains Semaglutide 7 mg, an oral anti-diabetic medicine used for the treatment of Type 2 Diabetes Mellitus in adults. It belongs to the GLP-1 receptor agonist class, which helps improve blood sugar control by increasing insulin secretion, reducing glucagon release, and slowing gastric emptying.

Rybelsus is the first oral GLP-1 medicine, offering a convenient alternative to injectable therapies. It helps control fasting and post-meal blood glucose levels and may also support weight management when used alongside a balanced diet and regular exercise.

Rybelsus 7 mg Tablet is generally prescribed as the starting dose, and may be increased to 14 mg if further glycemic control is needed. Regular use under medical supervision helps reduce the risk of long-term diabetes complications such as heart disease, kidney damage, and nerve problems.

⭐ Key Benefits

Controls fasting and post-meal blood sugar

Improves insulin secretion in a glucose-dependent manner

Supports weight management

Convenient once-daily oral tablet

Suitable for long-term Type 2 diabetes management

✅ Composition

Semaglutide 7 mg

🩺 Usage

Take Rybelsus 7 mg Tablet once daily on an empty stomach, at least 30 minutes before the first food, drink, or other oral medicines, with a small amount of water, or as directed by your doctor.

⚠️ Precautions

Not for use in Type 1 Diabetes or diabetic ketoacidosis

Use cautiously in patients with pancreatitis or severe gastrointestinal disorders

Avoid alcohol during treatment

Not recommended during pregnancy or breastfeeding unless advised

Monitor blood sugar levels regularly

📦 Delivery Information

✔️ Fast delivery across India

✔️ Safe, secure & tamper-proof packaging

🔄 Return Policy

✔️ Return accepted only if a wrong product is delivered

❌ No return if opened, used, or ordered incorrectly